nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisolone—ABCB1—ovarian cancer	0.328	1	CbGaD
Prednisolone—SLCO1A2—Chlorambucil—ovarian cancer	0.266	0.542	CbGbCtD
Prednisolone—ABCB1—Topotecan—ovarian cancer	0.0497	0.101	CbGbCtD
Prednisolone—ABCB1—Vinorelbine—ovarian cancer	0.035	0.0715	CbGbCtD
Prednisolone—CYP3A4—Topotecan—ovarian cancer	0.0298	0.0608	CbGbCtD
Prednisolone—ABCB1—Paclitaxel—ovarian cancer	0.0246	0.0502	CbGbCtD
Prednisolone—CYP3A4—Vinorelbine—ovarian cancer	0.021	0.0428	CbGbCtD
Prednisolone—ABCB1—Docetaxel—ovarian cancer	0.0178	0.0363	CbGbCtD
Prednisolone—CYP3A4—Paclitaxel—ovarian cancer	0.0148	0.0301	CbGbCtD
Prednisolone—ABCB1—Doxorubicin—ovarian cancer	0.0133	0.0271	CbGbCtD
Prednisolone—CYP3A4—Docetaxel—ovarian cancer	0.0107	0.0218	CbGbCtD
Prednisolone—CYP3A4—Doxorubicin—ovarian cancer	0.00795	0.0162	CbGbCtD
Prednisolone—SERPINA6—oviduct—ovarian cancer	0.00769	0.195	CbGeAlD
Prednisolone—NR3C2—myometrium—ovarian cancer	0.00201	0.0509	CbGeAlD
Prednisolone—NR3C2—uterine cervix—ovarian cancer	0.00156	0.0396	CbGeAlD
Prednisolone—SERPINA6—female reproductive system—ovarian cancer	0.00143	0.0364	CbGeAlD
Prednisolone—NR3C2—endometrium—ovarian cancer	0.00141	0.0358	CbGeAlD
Prednisolone—SERPINA6—bone marrow—ovarian cancer	0.00135	0.0343	CbGeAlD
Prednisolone—NR3C2—uterus—ovarian cancer	0.0013	0.033	CbGeAlD
Prednisolone—NR3C2—female reproductive system—ovarian cancer	0.00117	0.0297	CbGeAlD
Prednisolone—CYP2A6—vagina—ovarian cancer	0.00113	0.0286	CbGeAlD
Prednisolone—NR3C1—myometrium—ovarian cancer	0.00108	0.0273	CbGeAlD
Prednisolone—NR3C2—female gonad—ovarian cancer	0.00107	0.027	CbGeAlD
Prednisolone—NR3C2—vagina—ovarian cancer	0.00106	0.0269	CbGeAlD
Prednisolone—NR3C1—embryo—ovarian cancer	0.00104	0.0263	CbGeAlD
Prednisolone—NR3C2—testis—ovarian cancer	0.000945	0.024	CbGeAlD
Prednisolone—NR3C1—epithelium—ovarian cancer	0.000845	0.0214	CbGeAlD
Prednisolone—NR3C1—uterine cervix—ovarian cancer	0.000838	0.0213	CbGeAlD
Prednisolone—SLCO1A2—testis—ovarian cancer	0.00081	0.0205	CbGeAlD
Prednisolone—NR3C1—decidua—ovarian cancer	0.000798	0.0203	CbGeAlD
Prednisolone—NR3C1—endometrium—ovarian cancer	0.000758	0.0192	CbGeAlD
Prednisolone—NR3C1—gonad—ovarian cancer	0.000703	0.0178	CbGeAlD
Prednisolone—NR3C1—uterus—ovarian cancer	0.000698	0.0177	CbGeAlD
Prednisolone—NR3C2—lymph node—ovarian cancer	0.000685	0.0174	CbGeAlD
Prednisolone—NR3C1—female reproductive system—ovarian cancer	0.000628	0.0159	CbGeAlD
Prednisolone—NR3C1—bone marrow—ovarian cancer	0.000593	0.015	CbGeAlD
Prednisolone—ABCB1—myometrium—ovarian cancer	0.000577	0.0146	CbGeAlD
Prednisolone—NR3C1—female gonad—ovarian cancer	0.000571	0.0145	CbGeAlD
Prednisolone—NR3C1—vagina—ovarian cancer	0.000568	0.0144	CbGeAlD
Prednisolone—NR3C1—Regulation of Androgen receptor activity—SPDEF—ovarian cancer	0.000559	0.0518	CbGpPWpGaD
Prednisolone—ABCB1—embryo—ovarian cancer	0.000555	0.0141	CbGeAlD
Prednisolone—NR3C1—testis—ovarian cancer	0.000507	0.0129	CbGeAlD
Prednisolone—Betamethasone—PGR—ovarian cancer	0.000488	0.147	CrCbGaD
Prednisolone—CYP3A4—female reproductive system—ovarian cancer	0.000475	0.012	CbGeAlD
Prednisolone—Blister—Doxorubicin—ovarian cancer	0.000462	0.00361	CcSEcCtD
Prednisolone—Abscess—Epirubicin—ovarian cancer	0.000455	0.00356	CcSEcCtD
Prednisolone—ABCB1—epithelium—ovarian cancer	0.000453	0.0115	CbGeAlD
Prednisolone—Dermatitis atopic—Doxorubicin—ovarian cancer	0.00045	0.00352	CcSEcCtD
Prednisolone—ABCB1—uterine cervix—ovarian cancer	0.000449	0.0114	CbGeAlD
Prednisolone—Thrombophlebitis—Docetaxel—ovarian cancer	0.000448	0.0035	CcSEcCtD
Prednisolone—Neuritis—Doxorubicin—ovarian cancer	0.000446	0.00349	CcSEcCtD
Prednisolone—Stinging—Epirubicin—ovarian cancer	0.000445	0.00347	CcSEcCtD
Prednisolone—Ill-defined disorder—Topotecan—ovarian cancer	0.000444	0.00347	CcSEcCtD
Prednisolone—Petechiae—Epirubicin—ovarian cancer	0.000438	0.00342	CcSEcCtD
Prednisolone—Angioedema—Topotecan—ovarian cancer	0.000437	0.00342	CcSEcCtD
Prednisolone—Cardiac arrest—Paclitaxel—ovarian cancer	0.000435	0.0034	CcSEcCtD
Prednisolone—Mood swings—Paclitaxel—ovarian cancer	0.000433	0.00339	CcSEcCtD
Prednisolone—Malaise—Topotecan—ovarian cancer	0.000432	0.00337	CcSEcCtD
Prednisolone—Cardiac failure congestive—Docetaxel—ovarian cancer	0.000427	0.00334	CcSEcCtD
Prednisolone—ABCB1—decidua—ovarian cancer	0.000427	0.0108	CbGeAlD
Prednisolone—Abscess—Doxorubicin—ovarian cancer	0.000421	0.00329	CcSEcCtD
Prednisolone—Arrhythmia—Vinorelbine—ovarian cancer	0.00042	0.00328	CcSEcCtD
Prednisolone—Dry skin—Paclitaxel—ovarian cancer	0.000419	0.00328	CcSEcCtD
Prednisolone—Stinging—Doxorubicin—ovarian cancer	0.000411	0.00322	CcSEcCtD
Prednisolone—Erythema—Vinorelbine—ovarian cancer	0.00041	0.0032	CcSEcCtD
Prednisolone—Visual disturbance—Docetaxel—ovarian cancer	0.000409	0.0032	CcSEcCtD
Prednisolone—Convulsion—Melphalan—ovarian cancer	0.000406	0.00317	CcSEcCtD
Prednisolone—ABCB1—endometrium—ovarian cancer	0.000406	0.0103	CbGeAlD
Prednisolone—Dermatitis bullous—Docetaxel—ovarian cancer	0.000406	0.00317	CcSEcCtD
Prednisolone—Petechiae—Doxorubicin—ovarian cancer	0.000405	0.00317	CcSEcCtD
Prednisolone—Muscular weakness—Paclitaxel—ovarian cancer	0.000403	0.00315	CcSEcCtD
Prednisolone—Discomfort—Topotecan—ovarian cancer	0.000403	0.00315	CcSEcCtD
Prednisolone—Viral infection—Epirubicin—ovarian cancer	0.000399	0.00312	CcSEcCtD
Prednisolone—Abdominal distension—Paclitaxel—ovarian cancer	0.000398	0.00311	CcSEcCtD
Prednisolone—Arthropathy—Epirubicin—ovarian cancer	0.000396	0.0031	CcSEcCtD
Prednisolone—Fluoxymesterone—ESR1—ovarian cancer	0.000395	0.12	CrCbGaD
Prednisolone—Herpes simplex—Epirubicin—ovarian cancer	0.000391	0.00305	CcSEcCtD
Prednisolone—Anaphylactic shock—Topotecan—ovarian cancer	0.000391	0.00305	CcSEcCtD
Prednisolone—Pancreatitis—Paclitaxel—ovarian cancer	0.000388	0.00303	CcSEcCtD
Prednisolone—Sweating increased—Paclitaxel—ovarian cancer	0.000385	0.00301	CcSEcCtD
Prednisolone—Oedema—Melphalan—ovarian cancer	0.000383	0.00299	CcSEcCtD
Prednisolone—Anaphylactic shock—Melphalan—ovarian cancer	0.000383	0.00299	CcSEcCtD
Prednisolone—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00038	0.00297	CcSEcCtD
Prednisolone—Hyperhidrosis—Topotecan—ovarian cancer	0.000378	0.00295	CcSEcCtD
Prednisolone—ABCB1—gonad—ovarian cancer	0.000376	0.00955	CbGeAlD
Prednisolone—Pain—Chlorambucil—ovarian cancer	0.000375	0.00293	CcSEcCtD
Prednisolone—NR3C2—Nuclear Receptor transcription pathway—PGR—ovarian cancer	0.000375	0.0347	CbGpPWpGaD
Prednisolone—Angioedema—Vinorelbine—ovarian cancer	0.000374	0.00292	CcSEcCtD
Prednisolone—ABCB1—uterus—ovarian cancer	0.000374	0.00948	CbGeAlD
Prednisolone—Tachycardia—Melphalan—ovarian cancer	0.000373	0.00292	CcSEcCtD
Prednisolone—NR3C2—Preimplantation Embryo—SMARCA4—ovarian cancer	0.00037	0.0342	CbGpPWpGaD
Prednisolone—Malaise—Vinorelbine—ovarian cancer	0.000369	0.00289	CcSEcCtD
Prednisolone—Viral infection—Doxorubicin—ovarian cancer	0.000369	0.00288	CcSEcCtD
Prednisolone—Vertigo—Vinorelbine—ovarian cancer	0.000368	0.00288	CcSEcCtD
Prednisolone—NR3C1—lymph node—ovarian cancer	0.000367	0.00932	CbGeAlD
Prednisolone—Arthropathy—Doxorubicin—ovarian cancer	0.000367	0.00286	CcSEcCtD
Prednisolone—Herpes simplex—Doxorubicin—ovarian cancer	0.000362	0.00283	CcSEcCtD
Prednisolone—Feeling abnormal—Chlorambucil—ovarian cancer	0.000362	0.00283	CcSEcCtD
Prednisolone—Hiccups—Epirubicin—ovarian cancer	0.00036	0.00282	CcSEcCtD
Prednisolone—Weight increased—Paclitaxel—ovarian cancer	0.00036	0.00281	CcSEcCtD
Prednisolone—Dry skin—Docetaxel—ovarian cancer	0.000355	0.00278	CcSEcCtD
Prednisolone—Hypertension—Vinorelbine—ovarian cancer	0.000354	0.00276	CcSEcCtD
Prednisolone—Paraesthesia—Topotecan—ovarian cancer	0.000351	0.00274	CcSEcCtD
Prednisolone—Urticaria—Chlorambucil—ovarian cancer	0.000349	0.00272	CcSEcCtD
Prednisolone—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.000347	0.00272	CcSEcCtD
Prednisolone—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.000346	0.0027	CcSEcCtD
Prednisolone—Myocardial infarction—Paclitaxel—ovarian cancer	0.000346	0.0027	CcSEcCtD
Prednisolone—Discomfort—Vinorelbine—ovarian cancer	0.000344	0.00269	CcSEcCtD
Prednisolone—Paraesthesia—Melphalan—ovarian cancer	0.000344	0.00268	CcSEcCtD
Prednisolone—Conjunctivitis—Paclitaxel—ovarian cancer	0.000343	0.00268	CcSEcCtD
Prednisolone—Fluid retention—Epirubicin—ovarian cancer	0.000342	0.00267	CcSEcCtD
Prednisolone—Neuropathy—Epirubicin—ovarian cancer	0.000338	0.00264	CcSEcCtD
Prednisolone—ABCB1—female reproductive system—ovarian cancer	0.000336	0.00853	CbGeAlD
Prednisolone—NR3C1—Nuclear Receptors—NR5A1—ovarian cancer	0.000335	0.031	CbGpPWpGaD
Prednisolone—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000334	0.00261	CcSEcCtD
Prednisolone—Pain—Topotecan—ovarian cancer	0.000334	0.00261	CcSEcCtD
Prednisolone—Hiccups—Doxorubicin—ovarian cancer	0.000333	0.0026	CcSEcCtD
Prednisolone—Pain—Melphalan—ovarian cancer	0.000327	0.00256	CcSEcCtD
Prednisolone—Tachycardia—Vinorelbine—ovarian cancer	0.000326	0.00255	CcSEcCtD
Prednisolone—Ecchymosis—Epirubicin—ovarian cancer	0.000326	0.00255	CcSEcCtD
Prednisolone—Hypersensitivity—Chlorambucil—ovarian cancer	0.000323	0.00253	CcSEcCtD
Prednisolone—Bradycardia—Paclitaxel—ovarian cancer	0.000322	0.00252	CcSEcCtD
Prednisolone—Feeling abnormal—Topotecan—ovarian cancer	0.000322	0.00252	CcSEcCtD
Prednisolone—Pulmonary oedema—Epirubicin—ovarian cancer	0.000321	0.00251	CcSEcCtD
Prednisolone—Haemoglobin—Paclitaxel—ovarian cancer	0.000318	0.00249	CcSEcCtD
Prednisolone—ABCB1—bone marrow—ovarian cancer	0.000317	0.00805	CbGeAlD
Prednisolone—Fluid retention—Doxorubicin—ovarian cancer	0.000316	0.00247	CcSEcCtD
Prednisolone—Haemorrhage—Paclitaxel—ovarian cancer	0.000316	0.00247	CcSEcCtD
Prednisolone—Neuropathy—Doxorubicin—ovarian cancer	0.000313	0.00245	CcSEcCtD
Prednisolone—Urticaria—Topotecan—ovarian cancer	0.00031	0.00243	CcSEcCtD
Prednisolone—Progesterone—PGR—ovarian cancer	0.00031	0.0938	CrCbGaD
Prednisolone—ABCB1—female gonad—ovarian cancer	0.000306	0.00776	CbGeAlD
Prednisolone—Weight increased—Docetaxel—ovarian cancer	0.000305	0.00238	CcSEcCtD
Prednisolone—Visual impairment—Paclitaxel—ovarian cancer	0.000305	0.00238	CcSEcCtD
Prednisolone—ABCB1—vagina—ovarian cancer	0.000304	0.00771	CbGeAlD
Prednisolone—Urticaria—Melphalan—ovarian cancer	0.000304	0.00237	CcSEcCtD
Prednisolone—Thrombophlebitis—Epirubicin—ovarian cancer	0.000302	0.00236	CcSEcCtD
Prednisolone—Ecchymosis—Doxorubicin—ovarian cancer	0.000301	0.00236	CcSEcCtD
Prednisolone—Diabetes mellitus—Epirubicin—ovarian cancer	0.000301	0.00235	CcSEcCtD
Prednisolone—Paraesthesia—Vinorelbine—ovarian cancer	0.0003	0.00235	CcSEcCtD
Prednisolone—Pulmonary oedema—Doxorubicin—ovarian cancer	0.000297	0.00232	CcSEcCtD
Prednisolone—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000295	0.0023	CcSEcCtD
Prednisolone—Myocardial infarction—Docetaxel—ovarian cancer	0.000293	0.00229	CcSEcCtD
Prednisolone—Neuropathy peripheral—Docetaxel—ovarian cancer	0.000293	0.00229	CcSEcCtD
Prednisolone—Conjunctivitis—Docetaxel—ovarian cancer	0.00029	0.00227	CcSEcCtD
Prednisolone—Progesterone—CYP1B1—ovarian cancer	0.00029	0.0877	CrCbGaD
Prednisolone—Cardiac failure congestive—Epirubicin—ovarian cancer	0.000288	0.00225	CcSEcCtD
Prednisolone—Hypersensitivity—Topotecan—ovarian cancer	0.000288	0.00225	CcSEcCtD
Prednisolone—Pain—Vinorelbine—ovarian cancer	0.000286	0.00223	CcSEcCtD
Prednisolone—Dexamethasone—PGR—ovarian cancer	0.000284	0.0858	CrCbGaD
Prednisolone—Arrhythmia—Paclitaxel—ovarian cancer	0.000283	0.00221	CcSEcCtD
Prednisolone—Hypersensitivity—Melphalan—ovarian cancer	0.000282	0.0022	CcSEcCtD
Prednisolone—Thrombophlebitis—Doxorubicin—ovarian cancer	0.00028	0.00218	CcSEcCtD
Prednisolone—Increased appetite—Epirubicin—ovarian cancer	0.000278	0.00217	CcSEcCtD
Prednisolone—Diabetes mellitus—Doxorubicin—ovarian cancer	0.000278	0.00217	CcSEcCtD
Prednisolone—Erythema—Paclitaxel—ovarian cancer	0.000275	0.00215	CcSEcCtD
Prednisolone—Feeling abnormal—Vinorelbine—ovarian cancer	0.000275	0.00215	CcSEcCtD
Prednisolone—Testosterone—CYP1B1—ovarian cancer	0.000274	0.0829	CrCbGaD
Prednisolone—Dermatitis bullous—Epirubicin—ovarian cancer	0.000274	0.00214	CcSEcCtD
Prednisolone—ABCB1—testis—ovarian cancer	0.000271	0.00688	CbGeAlD
Prednisolone—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00027	0.00211	CcSEcCtD
Prednisolone—Haemoglobin—Docetaxel—ovarian cancer	0.00027	0.00211	CcSEcCtD
Prednisolone—Haemorrhage—Docetaxel—ovarian cancer	0.000268	0.0021	CcSEcCtD
Prednisolone—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.000267	0.00208	CcSEcCtD
Prednisolone—Urticaria—Vinorelbine—ovarian cancer	0.000266	0.00207	CcSEcCtD
Prednisolone—Dexamethasone—CYP1B1—ovarian cancer	0.000265	0.0802	CrCbGaD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—NR5A1—ovarian cancer	0.000265	0.0245	CbGpPWpGaD
Prednisolone—Osteoarthritis—Epirubicin—ovarian cancer	0.000261	0.00204	CcSEcCtD
Prednisolone—Nausea—Chlorambucil—ovarian cancer	0.000261	0.00204	CcSEcCtD
Prednisolone—Vision blurred—Paclitaxel—ovarian cancer	0.00026	0.00203	CcSEcCtD
Prednisolone—Visual impairment—Docetaxel—ovarian cancer	0.000258	0.00202	CcSEcCtD
Prednisolone—Dizziness—Topotecan—ovarian cancer	0.000258	0.00202	CcSEcCtD
Prednisolone—Increased appetite—Doxorubicin—ovarian cancer	0.000258	0.00201	CcSEcCtD
Prednisolone—Affect lability—Epirubicin—ovarian cancer	0.000257	0.00201	CcSEcCtD
Prednisolone—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000256	0.002	CcSEcCtD
Prednisolone—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000253	0.00198	CcSEcCtD
Prednisolone—Angioedema—Paclitaxel—ovarian cancer	0.000252	0.00197	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00025	0.00195	CcSEcCtD
Prednisolone—Cardiac arrest—Epirubicin—ovarian cancer	0.000249	0.00194	CcSEcCtD
Prednisolone—Malaise—Paclitaxel—ovarian cancer	0.000248	0.00194	CcSEcCtD
Prednisolone—Mood swings—Epirubicin—ovarian cancer	0.000248	0.00194	CcSEcCtD
Prednisolone—Vertigo—Paclitaxel—ovarian cancer	0.000247	0.00193	CcSEcCtD
Prednisolone—Syncope—Paclitaxel—ovarian cancer	0.000247	0.00193	CcSEcCtD
Prednisolone—Rash—Topotecan—ovarian cancer	0.000246	0.00193	CcSEcCtD
Prednisolone—Hypersensitivity—Vinorelbine—ovarian cancer	0.000246	0.00192	CcSEcCtD
Prednisolone—Dermatitis—Topotecan—ovarian cancer	0.000246	0.00192	CcSEcCtD
Prednisolone—Headache—Topotecan—ovarian cancer	0.000245	0.00191	CcSEcCtD
Prednisolone—Loss of consciousness—Paclitaxel—ovarian cancer	0.000242	0.00189	CcSEcCtD
Prednisolone—Osteoarthritis—Doxorubicin—ovarian cancer	0.000242	0.00189	CcSEcCtD
Prednisolone—Rash—Melphalan—ovarian cancer	0.000241	0.00188	CcSEcCtD
Prednisolone—Dermatitis—Melphalan—ovarian cancer	0.000241	0.00188	CcSEcCtD
Prednisolone—Dry skin—Epirubicin—ovarian cancer	0.00024	0.00187	CcSEcCtD
Prednisolone—Arrhythmia—Docetaxel—ovarian cancer	0.00024	0.00187	CcSEcCtD
Prednisolone—Convulsion—Paclitaxel—ovarian cancer	0.000239	0.00187	CcSEcCtD
Prednisolone—Affect lability—Doxorubicin—ovarian cancer	0.000238	0.00186	CcSEcCtD
Prednisolone—Hypertension—Paclitaxel—ovarian cancer	0.000238	0.00186	CcSEcCtD
Prednisolone—Erythema—Docetaxel—ovarian cancer	0.000233	0.00182	CcSEcCtD
Prednisolone—Nausea—Topotecan—ovarian cancer	0.000232	0.00181	CcSEcCtD
Prednisolone—Discomfort—Paclitaxel—ovarian cancer	0.000232	0.00181	CcSEcCtD
Prednisolone—Muscular weakness—Epirubicin—ovarian cancer	0.000231	0.0018	CcSEcCtD
Prednisolone—Cardiac arrest—Doxorubicin—ovarian cancer	0.00023	0.0018	CcSEcCtD
Prednisolone—Mood swings—Doxorubicin—ovarian cancer	0.000229	0.00179	CcSEcCtD
Prednisolone—Abdominal distension—Epirubicin—ovarian cancer	0.000228	0.00178	CcSEcCtD
Prednisolone—Nausea—Melphalan—ovarian cancer	0.000227	0.00178	CcSEcCtD
Prednisolone—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000225	0.00176	CcSEcCtD
Prednisolone—Oedema—Paclitaxel—ovarian cancer	0.000225	0.00176	CcSEcCtD
Prednisolone—Dry skin—Doxorubicin—ovarian cancer	0.000222	0.00173	CcSEcCtD
Prednisolone—Pancreatitis—Epirubicin—ovarian cancer	0.000222	0.00173	CcSEcCtD
Prednisolone—Shock—Paclitaxel—ovarian cancer	0.000221	0.00173	CcSEcCtD
Prednisolone—Dizziness—Vinorelbine—ovarian cancer	0.000221	0.00173	CcSEcCtD
Prednisolone—Tachycardia—Paclitaxel—ovarian cancer	0.000219	0.00171	CcSEcCtD
Prednisolone—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000217	0.0017	CcSEcCtD
Prednisolone—NR3C1—Signaling events mediated by HDAC Class II—HDAC6—ovarian cancer	0.000216	0.02	CbGpPWpGaD
Prednisolone—Muscular weakness—Doxorubicin—ovarian cancer	0.000213	0.00167	CcSEcCtD
Prednisolone—Rash—Vinorelbine—ovarian cancer	0.000211	0.00165	CcSEcCtD
Prednisolone—Dermatitis—Vinorelbine—ovarian cancer	0.000211	0.00165	CcSEcCtD
Prednisolone—Abdominal distension—Doxorubicin—ovarian cancer	0.000211	0.00165	CcSEcCtD
Prednisolone—Headache—Vinorelbine—ovarian cancer	0.000209	0.00164	CcSEcCtD
Prednisolone—Syncope—Docetaxel—ovarian cancer	0.000209	0.00164	CcSEcCtD
Prednisolone—CYP2A6—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000206	0.0191	CbGpPWpGaD
Prednisolone—Weight increased—Epirubicin—ovarian cancer	0.000206	0.00161	CcSEcCtD
Prednisolone—Loss of consciousness—Docetaxel—ovarian cancer	0.000205	0.0016	CcSEcCtD
Prednisolone—Pancreatitis—Doxorubicin—ovarian cancer	0.000205	0.0016	CcSEcCtD
Prednisolone—Insomnia—Paclitaxel—ovarian cancer	0.000203	0.00159	CcSEcCtD
Prednisolone—Convulsion—Docetaxel—ovarian cancer	0.000202	0.00158	CcSEcCtD
Prednisolone—Paraesthesia—Paclitaxel—ovarian cancer	0.000202	0.00158	CcSEcCtD
Prednisolone—Hypertension—Docetaxel—ovarian cancer	0.000202	0.00158	CcSEcCtD
Prednisolone—NR3C2—Nuclear Receptor transcription pathway—ESR1—ovarian cancer	0.0002	0.0185	CbGpPWpGaD
Prednisolone—Nausea—Vinorelbine—ovarian cancer	0.000199	0.00155	CcSEcCtD
Prednisolone—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000198	0.00154	CcSEcCtD
Prednisolone—ABCB1—lymph node—ovarian cancer	0.000197	0.00499	CbGeAlD
Prednisolone—Conjunctivitis—Epirubicin—ovarian cancer	0.000196	0.00153	CcSEcCtD
Prednisolone—Progesterone—ESR1—ovarian cancer	0.000196	0.0592	CrCbGaD
Prednisolone—Pain—Paclitaxel—ovarian cancer	0.000192	0.0015	CcSEcCtD
Prednisolone—Anaphylactic shock—Docetaxel—ovarian cancer	0.000191	0.00149	CcSEcCtD
Prednisolone—Oedema—Docetaxel—ovarian cancer	0.000191	0.00149	CcSEcCtD
Prednisolone—Weight increased—Doxorubicin—ovarian cancer	0.00019	0.00149	CcSEcCtD
Prednisolone—Methylprednisolone—ABCB1—ovarian cancer	0.000189	0.0573	CrCbGaD
Prednisolone—Shock—Docetaxel—ovarian cancer	0.000187	0.00146	CcSEcCtD
Prednisolone—Tachycardia—Docetaxel—ovarian cancer	0.000186	0.00145	CcSEcCtD
Prednisolone—Feeling abnormal—Paclitaxel—ovarian cancer	0.000185	0.00145	CcSEcCtD
Prednisolone—Bradycardia—Epirubicin—ovarian cancer	0.000184	0.00144	CcSEcCtD
Prednisolone—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000183	0.00143	CcSEcCtD
Prednisolone—Haemoglobin—Epirubicin—ovarian cancer	0.000182	0.00142	CcSEcCtD
Prednisolone—Conjunctivitis—Doxorubicin—ovarian cancer	0.000181	0.00142	CcSEcCtD
Prednisolone—Haemorrhage—Epirubicin—ovarian cancer	0.000181	0.00141	CcSEcCtD
Prednisolone—Urticaria—Paclitaxel—ovarian cancer	0.000179	0.0014	CcSEcCtD
Prednisolone—Visual impairment—Epirubicin—ovarian cancer	0.000174	0.00136	CcSEcCtD
Prednisolone—Insomnia—Docetaxel—ovarian cancer	0.000172	0.00135	CcSEcCtD
Prednisolone—Paraesthesia—Docetaxel—ovarian cancer	0.000171	0.00134	CcSEcCtD
Prednisolone—Bradycardia—Doxorubicin—ovarian cancer	0.00017	0.00133	CcSEcCtD
Prednisolone—Haemoglobin—Doxorubicin—ovarian cancer	0.000168	0.00131	CcSEcCtD
Prednisolone—Haemorrhage—Doxorubicin—ovarian cancer	0.000167	0.00131	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptors—PGR—ovarian cancer	0.000167	0.0154	CbGpPWpGaD
Prednisolone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000166	0.00129	CcSEcCtD
Prednisolone—Pain—Docetaxel—ovarian cancer	0.000163	0.00127	CcSEcCtD
Prednisolone—Arrhythmia—Epirubicin—ovarian cancer	0.000162	0.00126	CcSEcCtD
Prednisolone—Visual impairment—Doxorubicin—ovarian cancer	0.000161	0.00126	CcSEcCtD
Prednisolone—Erythema—Epirubicin—ovarian cancer	0.000157	0.00123	CcSEcCtD
Prednisolone—Feeling abnormal—Docetaxel—ovarian cancer	0.000157	0.00123	CcSEcCtD
Prednisolone—NR3C2—Preimplantation Embryo—CDH1—ovarian cancer	0.000157	0.0145	CbGpPWpGaD
Prednisolone—NR3C1—Endoderm Differentiation—HNF1B—ovarian cancer	0.000155	0.0144	CbGpPWpGaD
Prednisolone—CYP3A4—Liver X Receptor Pathway—FASN—ovarian cancer	0.00015	0.0139	CbGpPWpGaD
Prednisolone—Arrhythmia—Doxorubicin—ovarian cancer	0.00015	0.00117	CcSEcCtD
Prednisolone—Dizziness—Paclitaxel—ovarian cancer	0.000149	0.00116	CcSEcCtD
Prednisolone—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	0.000149	0.0138	CbGpPWpGaD
Prednisolone—Vision blurred—Epirubicin—ovarian cancer	0.000148	0.00116	CcSEcCtD
Prednisolone—Ill-defined disorder—Epirubicin—ovarian cancer	0.000146	0.00114	CcSEcCtD
Prednisolone—Erythema—Doxorubicin—ovarian cancer	0.000146	0.00114	CcSEcCtD
Prednisolone—Prednisone—ABCB1—ovarian cancer	0.000145	0.0438	CrCbGaD
Prednisolone—Malaise—Epirubicin—ovarian cancer	0.000142	0.00111	CcSEcCtD
Prednisolone—Rash—Paclitaxel—ovarian cancer	0.000142	0.00111	CcSEcCtD
Prednisolone—Dermatitis—Paclitaxel—ovarian cancer	0.000142	0.00111	CcSEcCtD
Prednisolone—Vertigo—Epirubicin—ovarian cancer	0.000141	0.00111	CcSEcCtD
Prednisolone—Syncope—Epirubicin—ovarian cancer	0.000141	0.0011	CcSEcCtD
Prednisolone—Headache—Paclitaxel—ovarian cancer	0.000141	0.0011	CcSEcCtD
Prednisolone—Hypersensitivity—Docetaxel—ovarian cancer	0.00014	0.0011	CcSEcCtD
Prednisolone—Loss of consciousness—Epirubicin—ovarian cancer	0.000138	0.00108	CcSEcCtD
Prednisolone—Vision blurred—Doxorubicin—ovarian cancer	0.000137	0.00107	CcSEcCtD
Prednisolone—Convulsion—Epirubicin—ovarian cancer	0.000136	0.00107	CcSEcCtD
Prednisolone—Hypertension—Epirubicin—ovarian cancer	0.000136	0.00106	CcSEcCtD
Prednisolone—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000135	0.00106	CcSEcCtD
Prednisolone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.000135	0.0125	CbGpPWpGaD
Prednisolone—Nausea—Paclitaxel—ovarian cancer	0.000134	0.00104	CcSEcCtD
Prednisolone—Discomfort—Epirubicin—ovarian cancer	0.000132	0.00104	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—PGR—ovarian cancer	0.000132	0.0122	CbGpPWpGaD
Prednisolone—Malaise—Doxorubicin—ovarian cancer	0.000131	0.00103	CcSEcCtD
Prednisolone—Vertigo—Doxorubicin—ovarian cancer	0.000131	0.00102	CcSEcCtD
Prednisolone—Betamethasone—ABCB1—ovarian cancer	0.000131	0.0396	CrCbGaD
Prednisolone—Syncope—Doxorubicin—ovarian cancer	0.000131	0.00102	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—NR5A1—ovarian cancer	0.00013	0.012	CbGpPWpGaD
Prednisolone—Oedema—Epirubicin—ovarian cancer	0.000129	0.001	CcSEcCtD
Prednisolone—Anaphylactic shock—Epirubicin—ovarian cancer	0.000129	0.001	CcSEcCtD
Prednisolone—Loss of consciousness—Doxorubicin—ovarian cancer	0.000128	0.001	CcSEcCtD
Prednisolone—Shock—Epirubicin—ovarian cancer	0.000126	0.000988	CcSEcCtD
Prednisolone—Convulsion—Doxorubicin—ovarian cancer	0.000126	0.000987	CcSEcCtD
Prednisolone—Dizziness—Docetaxel—ovarian cancer	0.000126	0.000985	CcSEcCtD
Prednisolone—Hypertension—Doxorubicin—ovarian cancer	0.000126	0.000983	CcSEcCtD
Prednisolone—Tachycardia—Epirubicin—ovarian cancer	0.000125	0.00098	CcSEcCtD
Prednisolone—Hyperhidrosis—Epirubicin—ovarian cancer	0.000124	0.000971	CcSEcCtD
Prednisolone—Discomfort—Doxorubicin—ovarian cancer	0.000123	0.000958	CcSEcCtD
Prednisolone—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000121	0.0112	CbGpPWpGaD
Prednisolone—Rash—Docetaxel—ovarian cancer	0.00012	0.000939	CcSEcCtD
Prednisolone—Dermatitis—Docetaxel—ovarian cancer	0.00012	0.000938	CcSEcCtD
Prednisolone—Headache—Docetaxel—ovarian cancer	0.000119	0.000933	CcSEcCtD
Prednisolone—Oedema—Doxorubicin—ovarian cancer	0.000119	0.000929	CcSEcCtD
Prednisolone—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000119	0.000929	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—ATF3—ovarian cancer	0.000119	0.011	CbGpPWpGaD
Prednisolone—Shock—Doxorubicin—ovarian cancer	0.000117	0.000914	CcSEcCtD
Prednisolone—Insomnia—Epirubicin—ovarian cancer	0.000116	0.000908	CcSEcCtD
Prednisolone—Tachycardia—Doxorubicin—ovarian cancer	0.000116	0.000907	CcSEcCtD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—TYMS—ovarian cancer	0.000116	0.0107	CbGpPWpGaD
Prednisolone—Paraesthesia—Epirubicin—ovarian cancer	0.000115	0.000902	CcSEcCtD
Prednisolone—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000115	0.000898	CcSEcCtD
Prednisolone—Nausea—Docetaxel—ovarian cancer	0.000113	0.000884	CcSEcCtD
Prednisolone—Pain—Epirubicin—ovarian cancer	0.00011	0.000859	CcSEcCtD
Prednisolone—Insomnia—Doxorubicin—ovarian cancer	0.000108	0.000841	CcSEcCtD
Prednisolone—Paraesthesia—Doxorubicin—ovarian cancer	0.000107	0.000834	CcSEcCtD
Prednisolone—Feeling abnormal—Epirubicin—ovarian cancer	0.000106	0.000828	CcSEcCtD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—ovarian cancer	0.000106	0.00979	CbGpPWpGaD
Prednisolone—Hydrocortisone—ABCB1—ovarian cancer	0.000102	0.0309	CrCbGaD
Prednisolone—Urticaria—Epirubicin—ovarian cancer	0.000102	0.000798	CcSEcCtD
Prednisolone—Pain—Doxorubicin—ovarian cancer	0.000102	0.000795	CcSEcCtD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—ovarian cancer	9.86e-05	0.00913	CbGpPWpGaD
Prednisolone—Feeling abnormal—Doxorubicin—ovarian cancer	9.8e-05	0.000766	CcSEcCtD
Prednisolone—NR3C1—Adipogenesis—RBL2—ovarian cancer	9.78e-05	0.00905	CbGpPWpGaD
Prednisolone—Hypersensitivity—Epirubicin—ovarian cancer	9.47e-05	0.00074	CcSEcCtD
Prednisolone—Urticaria—Doxorubicin—ovarian cancer	9.45e-05	0.000738	CcSEcCtD
Prednisolone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—ovarian cancer	9.08e-05	0.00841	CbGpPWpGaD
Prednisolone—NR3C1—Nuclear Receptors—ESR1—ovarian cancer	8.91e-05	0.00825	CbGpPWpGaD
Prednisolone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—ovarian cancer	8.91e-05	0.00825	CbGpPWpGaD
Prednisolone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	8.89e-05	0.00823	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—WDR77—ovarian cancer	8.78e-05	0.00813	CbGpPWpGaD
Prednisolone—CYP2A6—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	8.77e-05	0.00812	CbGpPWpGaD
Prednisolone—Hypersensitivity—Doxorubicin—ovarian cancer	8.76e-05	0.000685	CcSEcCtD
Prednisolone—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	8.54e-05	0.0079	CbGpPWpGaD
Prednisolone—Dizziness—Epirubicin—ovarian cancer	8.5e-05	0.000664	CcSEcCtD
Prednisolone—Progesterone—ABCB1—ovarian cancer	8.32e-05	0.0252	CrCbGaD
Prednisolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—ovarian cancer	8.3e-05	0.00768	CbGpPWpGaD
Prednisolone—Rash—Epirubicin—ovarian cancer	8.1e-05	0.000633	CcSEcCtD
Prednisolone—Dermatitis—Epirubicin—ovarian cancer	8.1e-05	0.000633	CcSEcCtD
Prednisolone—Headache—Epirubicin—ovarian cancer	8.05e-05	0.000629	CcSEcCtD
Prednisolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—ovarian cancer	7.89e-05	0.00731	CbGpPWpGaD
Prednisolone—Testosterone—ABCB1—ovarian cancer	7.86e-05	0.0238	CrCbGaD
Prednisolone—Dizziness—Doxorubicin—ovarian cancer	7.86e-05	0.000615	CcSEcCtD
Prednisolone—Nausea—Epirubicin—ovarian cancer	7.63e-05	0.000597	CcSEcCtD
Prednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—ovarian cancer	7.63e-05	0.00706	CbGpPWpGaD
Prednisolone—Dexamethasone—ABCB1—ovarian cancer	7.61e-05	0.023	CrCbGaD
Prednisolone—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	7.55e-05	0.00699	CbGpPWpGaD
Prednisolone—Rash—Doxorubicin—ovarian cancer	7.5e-05	0.000586	CcSEcCtD
Prednisolone—Dermatitis—Doxorubicin—ovarian cancer	7.49e-05	0.000585	CcSEcCtD
Prednisolone—Headache—Doxorubicin—ovarian cancer	7.45e-05	0.000582	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—YAP1—ovarian cancer	7.41e-05	0.00686	CbGpPWpGaD
Prednisolone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	7.36e-05	0.00681	CbGpPWpGaD
Prednisolone—CYP2A6—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	7.21e-05	0.00667	CbGpPWpGaD
Prednisolone—Nausea—Doxorubicin—ovarian cancer	7.06e-05	0.000552	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—ESR1—ovarian cancer	7.04e-05	0.00652	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—TTF1—ovarian cancer	6.89e-05	0.00638	CbGpPWpGaD
Prednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—ovarian cancer	6.83e-05	0.00632	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—PGR—ovarian cancer	6.47e-05	0.00599	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—NR5A1—ovarian cancer	6.26e-05	0.00579	CbGpPWpGaD
Prednisolone—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	6.2e-05	0.00574	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—PARP1—ovarian cancer	6.02e-05	0.00557	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	5.9e-05	0.00546	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—GADD45A—ovarian cancer	5.82e-05	0.00539	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—ESR1—ovarian cancer	5.47e-05	0.00506	CbGpPWpGaD
Prednisolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—ovarian cancer	5.39e-05	0.00499	CbGpPWpGaD
Prednisolone—NR3C1—Endoderm Differentiation—APC—ovarian cancer	5.29e-05	0.00489	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—ovarian cancer	5.11e-05	0.00473	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—ovarian cancer	4.86e-05	0.0045	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	4.81e-05	0.00445	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—SLC5A5—ovarian cancer	4.71e-05	0.00436	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—NR5A1—ovarian cancer	4.57e-05	0.00423	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—SLC2A1—ovarian cancer	4.55e-05	0.00421	CbGpPWpGaD
Prednisolone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	4.44e-05	0.00411	CbGpPWpGaD
Prednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	4.23e-05	0.00391	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—AQP3—ovarian cancer	4.15e-05	0.00384	CbGpPWpGaD
Prednisolone—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	4.13e-05	0.00382	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	4.1e-05	0.0038	CbGpPWpGaD
Prednisolone—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	4.03e-05	0.00373	CbGpPWpGaD
Prednisolone—SLCO1A2—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	3.99e-05	0.00369	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	3.98e-05	0.00368	CbGpPWpGaD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—TP53—ovarian cancer	3.85e-05	0.00356	CbGpPWpGaD
Prednisolone—CYP2A6—Biological oxidations—CYP1B1—ovarian cancer	3.83e-05	0.00354	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CXCL8—ovarian cancer	3.8e-05	0.00352	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CDKN1B—ovarian cancer	3.71e-05	0.00344	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—IL2—ovarian cancer	3.64e-05	0.00337	CbGpPWpGaD
Prednisolone—NR3C1—Endoderm Differentiation—CTNNB1—ovarian cancer	3.59e-05	0.00332	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—YAP1—ovarian cancer	3.57e-05	0.0033	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CCND1—ovarian cancer	3.54e-05	0.00328	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CTNNB1—ovarian cancer	3.51e-05	0.00325	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—ESR1—ovarian cancer	3.45e-05	0.0032	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—TERT—ovarian cancer	3.45e-05	0.0032	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—MMP9—ovarian cancer	3.44e-05	0.00318	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—PTEN—ovarian cancer	3.42e-05	0.00317	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—ovarian cancer	3.35e-05	0.0031	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—IL6ST—ovarian cancer	3.28e-05	0.00303	CbGpPWpGaD
Prednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	3.26e-05	0.00302	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—NME2—ovarian cancer	3.24e-05	0.003	CbGpPWpGaD
Prednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	3.22e-05	0.00298	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL2—ovarian cancer	3.2e-05	0.00297	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.14e-05	0.00291	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—PGR—ovarian cancer	3.12e-05	0.00288	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—WDR77—ovarian cancer	3.09e-05	0.00286	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—PARP1—ovarian cancer	2.9e-05	0.00268	CbGpPWpGaD
Prednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	2.86e-05	0.00265	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—MYC—ovarian cancer	2.84e-05	0.00263	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.75e-05	0.00255	CbGpPWpGaD
Prednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	2.65e-05	0.00246	CbGpPWpGaD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	2.64e-05	0.00245	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—YAP1—ovarian cancer	2.61e-05	0.00241	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—ovarian cancer	2.58e-05	0.00238	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	2.53e-05	0.00234	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—ovarian cancer	2.45e-05	0.00227	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—TTF1—ovarian cancer	2.43e-05	0.00224	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—PPP2R1A—ovarian cancer	2.35e-05	0.00217	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—TP53—ovarian cancer	2.33e-05	0.00216	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—NME2—ovarian cancer	2.33e-05	0.00216	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	2.3e-05	0.00213	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—PGR—ovarian cancer	2.28e-05	0.00211	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.24e-05	0.00208	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NR5A1—ovarian cancer	2.2e-05	0.00204	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—CTNNB1—ovarian cancer	2.14e-05	0.00198	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—IL6—ovarian cancer	2.14e-05	0.00198	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—PARP1—ovarian cancer	2.12e-05	0.00196	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	2.1e-05	0.00195	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.1e-05	0.00194	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CYTB—ovarian cancer	2.09e-05	0.00193	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—ovarian cancer	2.06e-05	0.0019	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.04e-05	0.00189	CbGpPWpGaD
Prednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	2.03e-05	0.00188	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.03e-05	0.00188	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	2e-05	0.00185	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	1.97e-05	0.00182	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	1.92e-05	0.00178	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—ovarian cancer	1.88e-05	0.00174	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—STAT3—ovarian cancer	1.86e-05	0.00173	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	1.86e-05	0.00172	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	1.85e-05	0.00171	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—BRIP1—ovarian cancer	1.83e-05	0.00169	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PPP1CC—ovarian cancer	1.83e-05	0.00169	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—MYC—ovarian cancer	1.8e-05	0.00166	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	1.78e-05	0.00165	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	1.78e-05	0.00164	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—CASP3—ovarian cancer	1.78e-05	0.00164	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—IL2—ovarian cancer	1.77e-05	0.00164	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	1.75e-05	0.00162	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	1.74e-05	0.00161	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—ovarian cancer	1.74e-05	0.00161	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	1.72e-05	0.0016	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	1.7e-05	0.00158	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	1.69e-05	0.00157	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—ESR1—ovarian cancer	1.66e-05	0.00154	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	1.63e-05	0.00151	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.6e-05	0.00148	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	1.51e-05	0.00139	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CYTB—ovarian cancer	1.5e-05	0.00139	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	1.4e-05	0.0013	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—NME2—ovarian cancer	1.39e-05	0.00129	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	1.38e-05	0.00128	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	1.35e-05	0.00125	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.33e-05	0.00123	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	1.32e-05	0.00122	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PPP1CC—ovarian cancer	1.31e-05	0.00122	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—BRIP1—ovarian cancer	1.31e-05	0.00122	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—IL6—ovarian cancer	1.3e-05	0.00121	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—YAP1—ovarian cancer	1.26e-05	0.00116	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	1.24e-05	0.00115	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—YAP1—ovarian cancer	1.23e-05	0.00113	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—ESR1—ovarian cancer	1.22e-05	0.00113	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.21e-05	0.00112	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—IL6—ovarian cancer	1.13e-05	0.00104	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.11e-05	0.00103	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—PGR—ovarian cancer	1.1e-05	0.00102	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.07e-05	0.000987	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—PARP1—ovarian cancer	1.02e-05	0.000944	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—FASN—ovarian cancer	9.99e-06	0.000925	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—SLC5A5—ovarian cancer	9.83e-06	0.00091	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	9.65e-06	0.000894	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—SLC2A1—ovarian cancer	9.49e-06	0.000878	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.29e-06	0.00086	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CYP1B1—ovarian cancer	9.1e-06	0.000842	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	8.98e-06	0.000831	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CYTB—ovarian cancer	8.95e-06	0.000828	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	8.94e-06	0.000828	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—MAPK3—ovarian cancer	8.9e-06	0.000823	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—YAP1—ovarian cancer	8.82e-06	0.000816	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	8.76e-06	0.000811	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	8.67e-06	0.000803	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—MYC—ovarian cancer	8.65e-06	0.000801	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—NME2—ovarian cancer	8.56e-06	0.000792	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	8.53e-06	0.000789	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	8.45e-06	0.000782	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—PPP2R1A—ovarian cancer	8.27e-06	0.000765	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	8.23e-06	0.000762	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PPP2R1A—ovarian cancer	8.07e-06	0.000747	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.03e-06	0.000743	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—BRIP1—ovarian cancer	7.82e-06	0.000724	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PPP1CC—ovarian cancer	7.82e-06	0.000724	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ABCB1—ovarian cancer	7.49e-06	0.000694	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	7.44e-06	0.000688	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—TYMS—ovarian cancer	7.36e-06	0.000681	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—FASN—ovarian cancer	7.19e-06	0.000665	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—SLC5A5—ovarian cancer	7.07e-06	0.000654	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	7.03e-06	0.000651	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	6.84e-06	0.000633	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—SLC2A1—ovarian cancer	6.83e-06	0.000632	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	6.69e-06	0.00062	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	6.69e-06	0.000619	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CYP1B1—ovarian cancer	6.55e-06	0.000606	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—MYC—ovarian cancer	6.33e-06	0.000586	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	6.32e-06	0.000585	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—AKT1—ovarian cancer	6e-06	0.000555	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CAV1—ovarian cancer	5.93e-06	0.000549	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—ESR1—ovarian cancer	5.86e-06	0.000542	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	5.81e-06	0.000538	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	5.8e-06	0.000537	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.66e-06	0.000524	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	5.62e-06	0.00052	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CYTB—ovarian cancer	5.51e-06	0.00051	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	5.4e-06	0.0005	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ABCB1—ovarian cancer	5.39e-06	0.000499	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—TYMS—ovarian cancer	5.29e-06	0.00049	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—YAP1—ovarian cancer	5.25e-06	0.000486	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—BRIP1—ovarian cancer	4.82e-06	0.000446	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PPP1CC—ovarian cancer	4.82e-06	0.000446	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	4.75e-06	0.000439	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	4.74e-06	0.000439	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—FASN—ovarian cancer	4.28e-06	0.000396	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CAV1—ovarian cancer	4.27e-06	0.000395	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—SLC5A5—ovarian cancer	4.21e-06	0.000389	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	4.14e-06	0.000383	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—SLC2A1—ovarian cancer	4.06e-06	0.000376	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CYP1B1—ovarian cancer	3.9e-06	0.000361	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PIK3CG—ovarian cancer	3.89e-06	0.00036	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PTEN—ovarian cancer	3.58e-06	0.000331	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PPP2R1A—ovarian cancer	3.45e-06	0.00032	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PIK3CD—ovarian cancer	3.42e-06	0.000316	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—YAP1—ovarian cancer	3.23e-06	0.000299	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—TYMS—ovarian cancer	3.15e-06	0.000292	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—MAPK3—ovarian cancer	3.13e-06	0.00029	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—MYC—ovarian cancer	3.05e-06	0.000282	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PIK3CB—ovarian cancer	2.98e-06	0.000276	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—FASN—ovarian cancer	2.63e-06	0.000244	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.59e-06	0.00024	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PTEN—ovarian cancer	2.57e-06	0.000238	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CAV1—ovarian cancer	2.54e-06	0.000235	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	2.52e-06	0.000234	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.5e-06	0.000232	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.4e-06	0.000222	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PIK3CG—ovarian cancer	2.31e-06	0.000214	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.13e-06	0.000197	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—AKT1—ovarian cancer	2.11e-06	0.000196	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—AKT1—ovarian cancer	2.06e-06	0.000191	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PIK3CD—ovarian cancer	2.03e-06	0.000188	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.98e-06	0.000183	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—TYMS—ovarian cancer	1.94e-06	0.00018	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PIK3CA—ovarian cancer	1.81e-06	0.000168	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PIK3CB—ovarian cancer	1.77e-06	0.000164	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CAV1—ovarian cancer	1.56e-06	0.000145	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PTEN—ovarian cancer	1.53e-06	0.000142	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—AKT1—ovarian cancer	1.48e-06	0.000137	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.42e-06	0.000132	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.25e-06	0.000116	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.09e-06	0.000101	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.08e-06	0.0001	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PTEN—ovarian cancer	9.43e-07	8.73e-05	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—AKT1—ovarian cancer	8.82e-07	8.17e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	6.65e-07	6.16e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—AKT1—ovarian cancer	5.44e-07	5.03e-05	CbGpPWpGaD
